Suchergebnisse - "Hsu, Lih-Ching"

PubPharm (93)

1

Sensitization of cancer cells to paclitaxel-induced apoptosis by canagliflozin

enthalten in: Biochemical pharmacology | 2024

von Huang, H. | Kung, F. | Huang, Y. | +3

2

A novel HDAC6 inhibitor interferes microtubule dynamics and spindle assembly checkpoint and sensitizes cisplatin-induced apoptosis in castration-resistant prostate cancer

enthalten in: The Prostate | 2024

von Ye, P. | Leu, W. | Yeh, T. | +11

3

Doxazosin inhibits vasculogenic mimicry in human non‑small cell lung cancer through inhibition of the VEGF‑A/VE‑cadherin/mTOR/MMP pathway

enthalten in: Oncology letters | 2024

von Hsu, J. | Leu, W. | Hsu, L. | +2

4

Cardenolide glycosides sensitize gefitinib-induced apoptosis in non-small cell lung cancer : inhibition of Na+/K+-ATPase serving as a switch-on mechanism

enthalten in: Naunyn-Schmiedeberg's archives of pharmacology | 2024

von Du, C. | Leu, W. | Jiang, Y. | +6

5

A novel HDAC6 inhibitor interferes microtubule dynamics and spindle assembly checkpoint and sensitizes cisplatin‐induced apoptosis in castration‐resistant prostate cancer

enthalten in: The Prostate | 2024

von Ye, P. | Leu, W. | Yeh, T. | +11

6

Mechanistic study of dual-function inhibitors targeting topoisomerase II and Rad51-mediated DNA repair pathway against castration-resistant prostate cancer

enthalten in: The Prostate | 2023

von Chiang, Y. | Leu, W. | Chen, Y. | +8

7

Design, Synthesis, and Evaluation of Glucose Transporter Inhibitor-SN38 Conjugates for Targeting Colorectal Cancer

enthalten in: Journal of medicinal chemistry | 2023

von Chiu, P. | Chang, C. | Huang, P. | +6

8

Anticancer Activity and Molecular Mechanisms of an Ursodeoxycholic Acid Methyl Ester-Dihydroartemisinin Hybrid via a Triazole Linkage in Hepatocellular Carcinoma Cells

enthalten in: Molecules (Basel, Switzerland) | 2023

von Hsu, Y. | Kung, F. | Huang, T. | +7

9

Discovery of New Glucose Uptake Inhibitors as Potential Anticancer Agents by Non-Radioactive Cell-Based Assays

enthalten in: Molecules (Basel, Switzerland) | 2022

von Hung, H. | Li, L. | Guh, J. | +2

10

The Combination of a Novel GLUT1 Inhibitor and Cisplatin Synergistically Inhibits Breast Cancer Cell Growth By Enhancing the DNA Damaging Effect and Modulating the Akt/mTOR and MAPK Signaling Pathways

enthalten in: Frontiers in pharmacology | 2022

von Weng, H. | Sung, C. | Hsu, J. | +4

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]